LifeMD (NASDAQ:LFMD) & DocGo (NASDAQ:DCGO) Critical Survey

DocGo (NASDAQ:DCGO) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Insider & Institutional Ownership

56.4% of DocGo shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 3.8% of DocGo shares are held by company insiders. Comparatively, 18.4% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares DocGo and LifeMD’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DocGo	-4.20%	-3.26%	-2.24%
LifeMD	-2.41%	N/A	-8.11%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for DocGo and LifeMD, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1	4	2	0	2.14
LifeMD	1	2	5	1	2.67

DocGo currently has a consensus price target of $3.24, suggesting a potential upside of 191.67%. LifeMD has a consensus price target of $13.17, suggesting a potential upside of 151.27%. Given DocGo’s higher possible upside, equities analysts clearly believe DocGo is more favorable than LifeMD.

Volatility and Risk

DocGo has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.

Earnings and Valuation

This table compares DocGo and LifeMD”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$616.55 million	0.18	$19.99 million	($0.19)	-5.84
LifeMD	$212.45 million	1.17	-$18.88 million	($0.21)	-24.95

DocGo has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Summary

LifeMD beats DocGo on 8 of the 15 factors compared between the two stocks.

About DocGo

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

About LifeMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.